PAVmed (PAVM)
(Delayed Data from NSDQ)
$1.79 USD
-0.09 (-4.79%)
Updated May 17, 2024 04:00 PM ET
After-Market: $1.82 +0.03 (1.68%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PAVM 1.79 -0.09(-4.79%)
Will PAVM be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PAVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAVM
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
New Strong Buy Stocks for March 27th
PAVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why PAVmed Inc. (PAVM) Is a Great 'Buy the Bottom' Stock Now
PAVmed Inc. (PAVM) Upgraded to Buy: Here's Why
PAVmed Inc. (PAVM) Upgraded to Strong Buy: Here's What You Should Know
Other News for PAVM
Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and PAVmed (PAVM)
PAVmed (PAVM) Receives a Buy from Lake Street
Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)
PAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
PAVmed Inc. (PAVM) Q1 2024 Earnings Call Transcript